World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , 

World Journal of Pharmaceutical
and Medical Research

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 4.639

ICV : 78.6

Abstract

EFFECT OF DIFFERENT EXCIPIENTS ON IN VITRO RELEASE OF CARVEDILOL ER TABLETS

Yamuna A. B, Rashmi Banik* and Manjula Talluri

ABSTRACT

Extended release matrix tablet formulation of carvedilol were developed and evaluated to observe the effect of different drug release retarding polymer i.e., (HPMC K4, Eudragit S100) on invitro drug release .Ten formulation (F1-F10) were prepared by direct compression technique. FTIR studies showed stable character of Carvedilol with polymer. The pre-formulation parameters such as bulk density, tapped density, angle of repose, compressibility index and hausner’s ratio were analysed for prepared granules before compression. The thickness, hardness, friability, weight variation and drug content uniformity was evaluated for tablets. The effect of this variable on the drug release profile of carvedilol was also studied. In-vitro drug release is performed in USP apparatus-II(Paddle) at pH 7.4 phosphate buffer and at pH 1.2 in HCl medium at 37 °C for 16 hr. F3 has shown improved % cumulative drug release compared to others. Also F3 has satisfied the IP specifications of 81% within 16 hr. The stability study of the tablets F3 was carried out according to ICH guidelines at 40±?C/75±5% RH for three months by storing the samples in stability chamber, No significant difference in % CDR was observed. The best fit of release kinetic was achieved with Higuchi model followed by zero order.

[Full Text Article]

Powered By WJPMR | All Right Reserved

WJPMR